Delivery Order SPE2DR25D3201-SPE2DR26FT7PP

<p>The Defense Logistics Agency issued a $15,510.40 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for ENBREL 50 mg/ml syringes under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 6, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a $29,144.65 delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for ENBREL 50 mg/mL syringes with a completion date of March 3, 2026. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at $999,999,999.00 and running through December 2026. This IDC provides comprehensive global pharmaceutical support across military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The...

The Defense Logistics Agency issued a $54,426.03 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for ENBREL 25 mg/0.5 ml syringes. This is a delivery order issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and running through December 2026. The order covers a specific pharmaceutical product with firm fixed pricing. Place of performance is Conshohocken, PA, the awardee's corporate...

<p>The Defense Logistics Agency issued a $18,471.46 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Enbrel 50 mg/ml syringes under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 3, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $42,943.97 delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for supply of Enbrel 50 mg/ml syringes.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is February 19, 2026. Pricing is firm fixed price with no set-aside applied.</p>

The Defense Logistics Agency issued a $23,282.79 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for Enbrel 50 mg/mL in 98 mL quantities (4-count). The order is issued under an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion...

<p>The Defense Logistics Agency issued a $26,720.17 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Enbrel 50 mg/ml syringes under firm fixed-price terms, with ultimate completion by March 9, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued without set-aside on a competitive basis.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 4, 2026, for Enbrel 50 mg/ml syringes with a ceiling value of $47,315.38, executed under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed pricing with an ultimate completion date of March 5, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a $41,726.92 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for ENBREL 50 MG/ML syringes with an ultimate completion date of February 25, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) SPE2DX, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA....

<p>The Defense Logistics Agency issued a $6,887.92 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for ENBREL 25 MG/0.5 ML syringes with an ultimate completion date of February 12, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>